SS Innovations International Inc. (NASDAQ: SSII) demonstrated its surgical robotics platform in a series of remote operations during October 2026 medical conferences in Spain and India, including a robotic-assisted cardiac procedure performed by a surgeon approximately 7,500 miles from the patient, according to the company. The demonstrations featured the SSi Mantra surgical robotic system and the SSi MantrAsana tele-surgeon console. At the 40th European Association for Cardio-Thoracic Surgery annual meeting in Barcelona, Chairman and CEO Dr. Sudhir Srivastava remotely performed an atrial septal defect procedure on a patient located in Bengaluru, India. The company also reported that four additional robotic telesurgeries were performed or broadcast during the inaugural Society of Robotic Surgery India conference, covering urological, colorectal, pediatric and gynecological procedures. As of October 23, 2026, SS Innovations said 205 telesurgeries had been performed with the SSi Mantra system, including cardiac procedures.
The announcements matter because they illustrate how remote robotic surgery could extend specialist expertise beyond major medical centers, potentially allowing patients in underserved or distant locations to receive care from experienced surgeons without travel. However, the company acknowledged that widespread adoption depends on clinical validation, connectivity and regulatory requirements. For investors and the medical technology industry, the demonstrations offer a signal of progress but not a guarantee of near-term commercialization. SS Innovations is pursuing U.S. Food and Drug Administration clearance for the SSi Mantra, with completion of the 510(k) review targeted for the first quarter of 2027; the timeline remains subject to the FDA’s review. FDA clearance would be a key milestone for U.S. market entry, but the company’s ability to meet that target and to translate telesurgery demonstrations into routine clinical use will be closely watched.
For a deeper look at the company’s technology and recent developments, see the SS Innovations (NASDAQ: SSII) profile and the full announcement at https://ibn.fm/EZFDT. The latest news and updates relating to SSII are available in the company’s newsroom at https://ibn.fm/SSII. The announcement was distributed through InvestorWire, a communications platform within the Dynamic Brand Portfolio at IBN, which provides services including editorial syndication to 5,000+ outlets and social media distribution. Full terms of use and disclaimers are available at https://www.InvestorWire.com/Disclaimer.
